Migraines are a significant risk factor for dementia

Dementia is the most common neurological disease in older adults, whereas headaches, including migraines, are the most common neurological disorder across all ages. In a recent study in the International Journal of Geriatric Psychiatry that included 679 community-dwelling adults aged 65 years and older, migraines were a significant risk factor for dementia, including Alzheimer's disease.

Identifying a mid-life risk factor for dementia, such as migraines, will allow for earlier detection of at-risk individuals. It may also help improve researchers' understanding of the biology of Alzheimer's disease and dementia.

We don't yet have any way to cure Alzheimer's disease, so prevention is key. Identifying a link to migraines provides us with a rationale to guide new strategies to prevent Alzheimer's disease."

Senior author Suzanne L. Tyas, PhD, University of Waterloo, Canada

Source:
Journal reference:

Morton, R.E. et al. (2019) Migraine and the risk of all‐cause dementia, Alzheimer's disease, and vascular dementia: A prospective cohort study in community‐dwelling older adults. International Journal of Geriatric Psychiatry. doi.org/10.1002/gps.5180.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New protein target offers promise for alleviating cognitive decline in Parkinson's disease